Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
50.20    0.10 (0.20%)
Bid:
50.00
Ask:
50.30
Spread: 0.30 (0.60%)
Market Cap: £317.70m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

12 Dec 2024 14:59

RNS Number : 9142P
Marston's PLC
12 December 2024
Β 

12 December 2024

Β 

Marston's PLC (the "Company") - Notification of Transactions of Directors/Persons Discharging Managerial Responsibility

Β 

Marston's PLC (the "Company") announces that on 11Β DecemberΒ 2024 the Director listed below exercised an award over ordinary shares in the Company under the Company's 2014 Long Term Incentive Plan, which had been granted on 12 DecemberΒ 2019.Β 

Β 

Director

Aggregate number of shares in respect of which LTIP Award exercised

Β 

Hayleigh Lupino

17,550

Β 

The Director also completed a separate acquisition of shares on 11Β DecemberΒ 2024.

Β 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

Β 

Enquiries: Bethan Raybould, General Counsel and Company Secretary, Marston's PLC, +44 (0) 1902 907250

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β Hayleigh Lupino

Β 

2

Β 

Reason for the notification

a)

Β 

Position/status

Director and PDMR (Chief Financial Officer)

Β 

b)

Β 

Initial notification /Amendment

Initial notification

Β 

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Marston's PLC

Β 

b)

Β 

LEI

LEI no. 213800Q6RP3ZJ2CZR962

Β 

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary shares of 7.375p each

Β 

Identification code

ISIN GB00B1JQDM80

Β 

b)

Β 

Nature of the transaction

Exercise of award under the Long Term Incentive Plan

Β 

c)

Β 

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

Β 

N/A

17,550

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

n/a single transaction

Β 

n/a single transaction

Β 

e)

Β 

Date of the transaction

2024-12-11

Β 

f)

Β 

Place of the transaction

Outside a trading venue

Β 

Β 

5

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Β 

Ordinary shares of 7.375p each

Β 

Identification code

ISIN GB00B1JQDM80

Β 

b)

Β 

Nature of the transaction

Purchase of shares by Hayleigh Lupino

Β 

c)

Β 

Price(s) and volume(s)

Β 

Price(s)

Volume(s)

Β 

Β£0.434838

45,736

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

n/a single transaction

Β 

n/a single transaction

Β 

e)

Β 

Date of the transaction

2024-12-11

Β 

f)

Β 

Place of the transaction

London Stock Exchange, Main Market (XLON)

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHEALAAFSXLFFA
Date   Source Headline
2nd Feb 20211:02 pmRNSForm 8.3 - Marston's PLC
2nd Feb 202112:00 pmRNSForm 8.5 (EPT/RI) Martson's Plc
2nd Feb 202111:17 amRNSForm 8.5 (EPT/RI)- Marston’s plc
2nd Feb 202111:16 amRNSForm 8.5 (EPT/RI) - Marston’s plc
2nd Feb 202111:03 amBUSFORM 8.3 - MARSTON'S PLC
1st Feb 20214:13 pmRNSForm 8.3 - Marstons Plc
1st Feb 20214:12 pmPRNForm 8.3 - Marston's plc OPD
1st Feb 20213:42 pmEQSForm 8.3 - The Vanguard Group, Inc.: Marston's plc
1st Feb 20213:29 pmRNSUpdate on Possible Offer
1st Feb 20213:28 pmRNSForm 8.3 - Marston's plc
1st Feb 20213:20 pmRNSForm 8.3 - Marston's PLC
1st Feb 20213:00 pmBUSForm 8.3 - MARS LN
1st Feb 20212:58 pmRNSForm 8.3 - Marston's Plc
1st Feb 20212:44 pmPRNForm 8.3 - Marston’s plc
1st Feb 20212:23 pmRNSForm 8.3 - Marston's plc
1st Feb 20212:01 pmBUSForm 8.3 - MARSTON'S PLC
1st Feb 202112:32 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - MARSTON'S PLC - Ordinary Shares
1st Feb 202112:12 pmRNSRule 2.9 Announcement
1st Feb 202112:00 pmRNSForm 8.5 (EPT/RI) Martson's Plc
1st Feb 202111:47 amRNSForm 8.5 (EPT/RI)- Marston’s plc
1st Feb 202111:41 amRNSForm 8.3 - Marston's plc
1st Feb 202111:34 amRNSForm 8.3 - Marston's PLC
1st Feb 20217:00 amRNSRule 2.9 Announcement
29th Jan 20215:56 pmRNSForm 8.3 - [Marston's PLC]
29th Jan 20214:59 pmRNSRule 2.9 Announcement
29th Jan 202112:25 pmRNSForm 8.3 - Marston's PLC
29th Jan 202111:24 amRNSStatement regarding press speculation
27th Jan 202110:21 amRNSResult of AGM
12th Jan 20218:25 amRNSBlock listing Interim Review
8th Jan 20217:00 amRNSQ1 Update
24th Dec 202012:07 pmRNSAnnual Financial Report
23rd Dec 20207:00 amRNSMarston’s PLC to operate SA Brain pub estate
10th Dec 20207:00 amRNSRESULTS FOR THE 53 WEEKS ENDED 3 OCTOBER 2020
3rd Dec 202010:34 amRNSCOVID-19 Update: Result Noteholder Consent Request
11th Nov 20208:10 amRNSCOVID-19 Update re: Noteholder Consent Request
30th Oct 20202:41 pmRNSCompletion of brewing JV with Carlsberg UK
15th Oct 20207:00 amRNSYear End Trading Update
13th Oct 202011:14 amRNSNotice of Trading Update Announcement Revised Date
9th Oct 20207:09 amRNSCMA CLEARANCE OF JOINT VENTURE WITH CARLSBERG
1st Oct 20207:00 amRNSNotification of Trading Update Announcement Date
22nd Sep 202012:46 pmRNSHolding(s) in Company
7th Aug 20208:00 amRNSAppointment of Joint Corporate Broker
23rd Jul 202012:00 pmRNSTransaction Update
10th Jul 20209:03 amRNSBlock listing Interim Review
2nd Jul 20207:00 amRNSDirector/PDMR Shareholding
29th Jun 20202:30 pmRNSDirector/PDMR Shareholding
29th Jun 20201:36 pmRNSDirector Declaration
29th Jun 20209:27 amRNSDirector/PDMR Shareholding
26th Jun 20207:00 amRNSInterim Results
25th Jun 20209:23 amRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.